Lise Lund Kjems's most recent trade in Cyclo Therapeutics Inc - Ordinary Shares - Class A was a trade of 55,453 Stock Option (Right to buy) done . Disclosure was reported to the exchange on March 7, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cyclo Therapeutics Inc - O... | Lise Lund Kjems | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2023 | 55,453 | 55,453 | - | - | Stock Option (Right to buy) | |
| Cyclo Therapeutics Inc - O... | Lise Lund Kjems | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2022 | 31,141 | 31,141 | - | - | Stock Option (Right to buy) | |
| Cyclo Therapeutics Inc - O... | Lise Lund Kjems | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2021 | 23,800 | 23,800 | - | - | Stock Option (Right to buy) | |
| Cyclo Therapeutics Inc - O... | Lise Lund Kjems | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Sep 2021 | 17,053 | 17,053 | - | 0 | Common Stock |